Division of Biosensors International Pte. Ltd./Devax Inc.
Latest From Devax Inc.
BioStar Ventures, founded by physicians who are leaders in the interventional cardiology field, is demonstrating how medical device investors might benefit with close ties to clinical and corporate worlds.
The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Elsevier's Strategic Transactions
A roundup of recent medtech strategic alliances, mergers & acquisitions and financings.
Device companies large and small have failed repeatedly in efforts to address bifurcations, which remain one of the largest unmet opportunities in cardiology. Cappella thinks it can solve the problem with a device that's a new version of an old idea, reversing current protocol to treat the side branch first.
- Implantable Devices
- Surgical Equipment & Devices
- Drug Delivery
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Biosensors International Pte. Ltd.
- Senior Management
Paul R Buckman, CEO
Stephen L Wilson, EVP & CFO
R. John Elicker, VP, R&D
Christopher A Hubbard, VP, Sales & Mktg.
- Contact Info
Phone: (949) 334-2333
20996 Bake Pkwy.
Lake Forest, CA 92630
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.